Nov 8, 2014 | Research News
Making the T1D Vaccine a Reality By Emily Howell October 15, 2014 Nanoparticle-based vaccine is designed to re-educate the immune system and halt the attack on the pancreas Over the last three years, Selecta Bioscience, a clinical stage biotechnology company, has...
Nov 7, 2014 | Featured, Research News
As reported in the UAB (University of Alabama – Birmingham) News by Tyler Greer November 06, 2014 The “repurposing of verapamil as a beta cell survival therapy in type 1 diabetes” trial will test an approach different from any current diabetes treatment. New...